Extracardiac Prothrombotic Effects of COVID-19
- PMID: 35851457
- PMCID: PMC8960156
- DOI: 10.1016/j.ccl.2022.03.008
Extracardiac Prothrombotic Effects of COVID-19
Abstract
COVID-19 infection triggers a heightened inflammatory response which in turn, increases thrombosis and thromboembolism. Microvascular thrombosis has been detected in various tissue beds which may account for some of the multi-system organ dysfunction associated with COVID-19. Additional research is needed to understand which prophylactic and therapeutic drug regimens are best for the prevention and treatment of thrombotic complications of COVID-19.
Keywords: COVID-19; Deep vein thrombosis; Myocardial infarction; Pulmonary embolism; SARS-CoV-2; Stroke; Thrombosis.
Copyright © 2022 Elsevier Inc. All rights reserved.
Figures
References
-
- Organization W.H. WHO coronavirus (COVID-19) Dashboard. 2021. https://covid19.who.int Available at: Accessed October 1, 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
